Chart based progressive global trading strategies, Chart Partners

Thomas Schroeder

Chart based progressive global trading strategies

Chart Partners

Chart Partners objective is to discover medium-term cycle turns and profit opportunities before they unfold, within structural trends while preserving capital with clear degrees of risk. We have real return ideas. 

Markets are dynamic and trading systems must reflect this. It is crucial to determine underlying correlations and lead-lag relationships within global markets and the impact on linked instruments. Our weekly Chartonics product gives you short-term trading strategies that can be applied within the medium and longer term macro trends that are mapped out in our strategy updates. 

Our methodology fuses global market variables and isolates drivers in trends. We specialize in FX, index trade in NY and Asia with a focus on Asian stocks. 

Technical Analysis

<div>As RSI's in the US pullback from overbought territory and move into buy territory, the favored trade is to buy weakness for a reaction rise. Poor bull energy on a secondary rally attempt is vital in confirming a bigger cycle peak or wave 2 top. September/October months vulnerable is a recovery fizzles and we then convincingly break below pivotal trendline supports at NDX 11,300 and SPX 3,440. A top below 3,530 would set up a harder decline. Clearing 3,530 is the level that would try for a new high or re test of 3,586 with projection at 3,600 and 3,650.</div><div></div><div>Macro: Views this pullback as corrective barring a more impulsive follow through decline below 3,300 and 3,220.</div><div></div><div>Trade points are outlined on the long and short side with the DJI a favored long and the Russell 2000 remaining an underperform short. Given a bit more tech fallout we want are a buyer of the NDX as long as 11,000 holds bear pressure.</div>

As RSI's in the US pullback from overbought territory and move into buy territory, the favored trade is to buy weakness for a reaction rise. Poor bull energy on a secondary rally attempt is vital in confirming a bigger cycle peak or wave 2 top. September/October months vulnerable is a recovery fizzles and we then convincingly break below pivotal trendline supports at NDX 11,300 and SPX 3,440. A top below 3,530 would set up a harder decline. Clearing 3,530 is the level that would try for a new high or re test of 3,586 with projection at 3,600 and 3,650.Macro: Views this pullback as corrective barring a more impulsive follow through decline below 3,300 and 3,220.Trade points are outlined on the long and short side with the DJI a favored long and the Russell 2000 remaining an underperform short. Given a bit more tech fallout we want are a buyer of the NDX as long as 11,000 holds bear pressure.

SPX and NDX Long Short Levels and Sector Bets

Health Care Select Sector SPDR / Technical Analysis

<p>Our insight <a href="https://www.smartkarma.com/insights/core-us-sectors-leading-an-s-p-major-support-break" target="_blank" data-smartkarma-citation="insights:26732">Core US Sectors Leading an S&amp;P Major Support Break</a> outlined the lead breaks in small caps, financials and transports that signals a break lower in the S&amp;P.</p><p>We now turn to the last bastion of strength that would induce a high momentum decline below SPX 2,550. Defensive sectors in the US now face late cycle selling now that core lead sectors are breaking lower.</p><p>US healthcare and consumer staples have been a core outperform pair over being short the S&amp;P and has served us well with ominous peak signals in the making.</p><p>US healthcare ETF (XLV) chart is used as the safe haven proxy that would induce a big inflection point for US equities.</p>

Our insight Core US Sectors Leading an S&amp;P Major Support Break outlined the lead breaks in small caps, financials and transports that signals a break lower in the S&amp;P.We now turn to the last bastion of strength that would induce a high momentum decline below SPX 2,550. Defensive sectors in the US now face late cycle selling now that core lead sectors are breaking lower.US healthcare and consumer staples have been a core outperform pair over being short the S&amp;P and has served us well with ominous peak signals in the making.US healthcare ETF (XLV) chart is used as the safe haven proxy that would induce a big inflection point for US equities.

This Is the Chart that Would Cause a Mini Crash in the US

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

<p>Recent comments from Fed Chair Powell and the U.S.-China 90-day ceasefire agreement have drastically diminished (for now) concerns over two major sources of investor angst: (1) the pace of Fed tightenings and (2) trade policy. The S&amp;P 500 has opened trading today near the 2,817 resistance, a key level we are monitoring. The impending breakout - or breakdown below ~2,600 support, if resistance holds - will be key in determining where the market goes next.  In this report we highlight actionable Industry ETFs, broad EM ETFs and actionable Int’l ETFs, as well as sector rating changes: we are downgrading Technology (XLK) and upgrading Financials (XLF).</p>

Recent comments from Fed Chair Powell and the U.S.-China 90-day ceasefire agreement have drastically diminished (for now) concerns over two major sources of investor angst: (1) the pace of Fed tightenings and (2) trade policy. The S&amp;P 500 has opened trading today near the 2,817 resistance, a key level we are monitoring. The impending breakout - or breakdown below ~2,600 support, if resistance holds - will be key in determining where the market goes next.  In this report we highlight actionable Industry ETFs, broad EM ETFs and actionable Int’l ETFs, as well as sector rating changes: we are downgrading Technology (XLK) and upgrading Financials (XLF).

Global ETF Synopsis: Highlighting Technical Trends Across the ETF Universe

United States

Health Care Select Sector SPDR Fund is an exchange-traded fund incorporated in the USA.  The Fund's objective is to provide investment results that correspond to the performance of The Health Care Select Sector Index.  The Index includes companies involved in health care equipment and supplies, health care providers and services, biotechnology & pharmaceuticals.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Health Care Select Sector SPDR (XLV US)

SPX and NDX Long Short Levels and Sector Bets

As RSI's in the US pullback from overbought territory and move into buy territory, the favored trade is to buy weakness for a reaction rise. Poor...

Thomas Schroeder

This Is the Chart that Would Cause a Mini Crash in the US

Our insight Core US Sectors Leading an S&P Major Support Break outlined the lead breaks in small caps, financials and transports that signals a...

Thomas Schroeder

Global ETF Synopsis: Highlighting Technical Trends Across the ETF Universe

Recent comments from Fed Chair Powell and the U.S.-China 90-day ceasefire agreement have drastically diminished (for now) concerns over two major...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)